BSI Recognises Our Strong Commitment To Compliance
Earlier this month our production facility was audited by BSI (British Standards Institution) to ensure we continue to meet the requirements of the ISO 9001:2015 quality management standard as well as the PS 9000:2016 pharmaceutical code or practice.
A strong commitment to compliance with ISO 9001 and PS9000 as well as statutory and regulatory requirements continues to be key to our organisation's strategy of focussing on relatively short runs of higher-value products for the pharma sector with quick response times.
In the areas assessed, (which included pre-press, printing, and finishing, as well as final release, and training), we had a good depth of compliance. No new NCRs were raised (and there were none to clear from the last report).